Rafferty Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Sell
199,829
-27,840
-12% -$1.94M 0.05% 208
2025
Q4
$15.1M Buy
227,669
+2,636
+1% +$170K 0.05% 208
2025
Q3
$15.1M Buy
225,033
+36,347
+19% +$2.88M 0.05% 213
2025
Q2
$16.5M Sell
188,686
-19,553
-9% -$1.53M 0.05% 178
2025
Q1
$14.2M Buy
208,239
+3,380
+2% +$276K 0.06% 194
2024
Q4
$15.9M Sell
204,859
-2,427
-1% -$180K 0.06% 194
2024
Q3
$13.9M Buy
207,286
+57,508
+38% +$4.72M 0.05% 229
2024
Q2
$17M Buy
149,778
+14,548
+11% +$1.84M 0.06% 172
2024
Q1
$18.8M Buy
135,230
+7,641
+6% +$960K 0.07% 157
2023
Q4
$15.8M Sell
127,589
-387
-0.3% -$39.5K 0.07% 174
2023
Q3
$11.9M Buy
127,976
+32,941
+35% +$3.71M 0.07% 177
2023
Q2
$12.2M Buy
95,035
+10,084
+12% +$1.22M 0.07% 170
2023
Q1
$9.87M Buy
84,951
+9,255
+12% +$1.04M 0.07% 185
2022
Q4
$8.57M Sell
75,696
-26,424
-26% -$2.9M 0.07% 230
2022
Q3
$8.22M Sell
102,120
-6,384
-6% -$541K 0.09% 175
2022
Q2
$8.09M Buy
108,504
+35,472
+49% +$3.24M 0.07% 181
2022
Q1
$9.34M Buy
73,032
+30,320
+71% +$3.32M 0.06% 208
2021
Q4
$5.73M Sell
42,712
-5,028
-11% -$722K 0.03% 326
2021
Q3
$6.53M Buy
47,740
+4,740
+11% +$598K 0.04% 245
2021
Q2
$4.59M Sell
43,000
-5,548
-11% -$533K 0.03% 341
2021
Q1
$4.36M Buy
48,548
+888
+2% +$83.4K 0.03% 313
2020
Q4
$4.41M Buy
47,660
+12,188
+34% +$1.09M 0.04% 244
2020
Q3
$3.66M Sell
35,472
-296
-0.8% -$30.9K 0.04% 235
2020
Q2
$3.63M Buy
+35,768
New +$3.2M 0.05% 232
2020
Q1
Sell
-6,492
Closed -$355K 657
2019
Q4
$355K Sell
6,492
-3,452
-35% -$164K 0.01% 754
2019
Q3
$371K Sell
9,944
-6,476
-39% -$252K 0.01% 725
2019
Q2
$615K Buy
+16,420
New +$516K 0.01% 643

Other funds holding DXCM

Rafferty Asset Management's DXCM Position: Q1 2026 in Review

Rafferty Asset Management reduced its DexCom (DXCM) stake by 12% in Q1 2026, selling an estimated $1.94M and leaving 199,829 shares worth $12.5M. The position accounts for 0.05% of the portfolio, ranked #208.

Rafferty Asset Management first reported a position in DXCM in Q2 2019 and has held it in 27 quarters since. The position peaked at $18.8M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Rafferty Asset Management held 199,829 shares of DexCom worth $12.5M as of Q1 2026.
  • Rafferty Asset Management sold 27,840 DexCom shares in Q1 2026, an estimated $1.94M.
  • DexCom made up 0.05% of Rafferty Asset Management's portfolio in Q1 2026, its #208 holding.
  • Rafferty Asset Management first reported a position in DexCom in Q2 2019 and has held it in 27 quarters since.
  • Rafferty Asset Management's DexCom position peaked at $18.8M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.